CURRICULUM VITAE Eric J. Lenze, M.D. - Institute for Public Health

1. Psychiatric Symptoms Endorsed by Somatization Disorder Patients in a Psychiatric Clinic,”
Grand Rounds, Department of Psychiatry, Washington University, May 1998
2. "Results of a Resident Satisfaction Survey," Grand Rounds, Department of Psychiatry,
Washington University, May 1998
3. “Psychiatric Symptoms Endorsed by Somatization Disorder Patients in a Psychiatric Clinic,”
George Winnokur award presentation, American Association of Clinical Psychiatry annual
meeting, November 2000
4. “Developing Your Research Career,” American Association for Geriatric Psychiatry annual
meeting, February 2001
5. “Effects of Therapeutic Sleep Deprivation on Speed of Antidepressant Response in Elderly
Depressed Patients,” International College of Geriatric Psychoneuropharmacology annual
meeting, Barcelona, October 2002
6. “Persistent Depression in Elderly Persons is Associated with Cognitive Decline: Longitudinal
Findings from the Cardiovascular Health Study,” AAGP annual meeting, Honolulu, March 2003
7. “Anxiety Disorders in Late Life” Symposium chairman, ICGP annual meeting, San Juan, PR,
December 2003
8. “Treatment of Geriatric Anxiety Disorders: Results from a Placebo-Controlled Study of
Citalopram,” ICGP annual meeting, San Juan, PR, December 2003
9. “New Research in Late-Life Generalized Anxiety Disorder” Symposium chairman, AAGP annual
meeting, Baltimore, MD, February 2004
10. “Pharmacologic Management of Late-Life Generalized Anxiety Disorder,” AAGP annual meeting,
Baltimore, MD, February 2004
11. “The Interface of Late-Life Depression and Physical Rehabilitation,” AAGP annual meeting,
Baltimore, MD, February 2004
12. “Cognitive and Affective Factors as Predictors of Hip Fracture Recovery in the Elderly,” AACP
annual meeting, Ft. Lauderdale, FL, March 2004
13. “Gene-Environment Interactions in Late Life Mental Disorders,” NCDEU meeting, Phoenix, AZ,
June 2004
14. “5-HTTLPR as a risk gene for late-life depression after hip fracture: implications for
depression prevention.” ICGP annual meeting, Basel, Switzerland, October 2004
15. “Treatment of anxiety in late life.” AAGP annual meeting, San Diego, CA, March 2005
16. “Pharmacotherapy for late-life anxiety: results of a 32-week study with citalopram.” ADAA
annual meeting, Seattle, WA, March 2005
17. “Late-life depression and medical illness.” APA annual meeting, Atlanta, GA, May 2005.
18. “Somatic symptoms in late-life anxiety: treatment issues in primary care.” ABCT annual
meeting, Washington, DC, November 2005.
19. Chair of symposium, “Developing your research career”, AAGP annual meeting, San Juan,
PR, March 2006.
20. Chairman of symposium and speaker, “New research on late-life anxiety disorders”, AAGP
annual meeting, San Juan, PR, March 2006.
21. Chairman of symposium and speaker, “New opportunities for preventing depression in late
life”, AAGP annual meeting, San Juan, PR, March 2006.
22. “Medication management of late-life anxiety disorders”, ADAA annual meeting, Miami, FL,
March 2006.
23. “How to treat in the absence of scientific evidence: a focus on anxiety disorders in the
4